|
41
|
Product specific BE guideline |
Cholestyramine Powder-學名藥生體相等性試驗指導原則
|
2025-11-05 |
|
42
|
Product specific BE guideline |
Edoxaban Tosylate Tablet-學名藥生體相等性試驗指導原則
|
2025-11-05 |
|
43
|
Product specific BE guideline |
Deferasirox Tablet for suspension_生體相等性試驗指導原則
|
2021-11-22 |
|
44
|
Product specific BE guideline |
Gefitinib Tablet _生體相等性試驗指導原則
|
2021-11-22 |
|
45
|
Product specific BE guideline |
Azacitidine Lyophilized Powder for Injection_生體相等性試驗指導原則
|
2021-11-22 |
|
46
|
Product specific BE guideline |
Abiraterone acetate tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
47
|
Product specific BE guideline |
Amlodipine + Atorvastatin tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
48
|
Product specific BE guideline |
Dutasteride capsule_生體相等性試驗指導原則
|
2021-11-22 |
|
49
|
Product specific BE guideline |
Esomeprazole magnesium delayed release tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
50
|
Product specific BE guideline |
Imatinib Mesylate Tablets_生體相等性試驗指導原則
|
2021-11-22 |
